Literature DB >> 1017596

The application of caerulein to cholangiography.

S Nakazawa, Y Naito, Y Yamamoto, H Yamase, K Sobue, M Ichikawa, T Hattori.   

Abstract

Caerulein was applied to oral cholecystography and the opacity of the common bile duct was evaluated at intervals. To 127 subjects whose gallbladder had been visualized by cholecystography was administered caerulein by intramuscular route in a dose of 0.2 mug per kg of body weight. As a result: 1. The visualization of the common bile duct reached its maximum 15 minutes after administration of caerulein (52% of the subjects); in total, 62.2% of the subjects responded to this cholecystography. 2. The visualization by caerulein was superior to that by the yolk both in its rate and intensity. 3. The cholangiogram taken after administration of caerulein was preferably available for diagnosis of bile duct lesions. Caerulein used for a pretreatment of drip infusion cholangiography (DIC) remarkably improved the picture in 3 of the 10 subjects in whom DIC alone had failed to show the bile duct. Thus, the application of caerulein to cholangiography facilitated diagnosis of bile duct lesions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1017596     DOI: 10.1007/BF02777375

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  7 in total

1.  Secretin, pancreozymin, and cholecystokinin; their preparation and properties.

Authors:  J E JORPES; V MUTT
Journal:  Gastroenterology       Date:  1959-03       Impact factor: 22.682

2.  [Use of cholecystokinin in cholecystography].

Authors:  E ADLERCREUTZ; E JORPES; V MUTT; C WEGELIUS
Journal:  Arch Mal Appar Dig Mal Nutr       Date:  1957-05

3.  Experiments with cholecystokinin in cholecystography.

Authors:  B BRODEN
Journal:  Acta radiol       Date:  1958-01       Impact factor: 1.990

4.  The action of caerulein on pancreatic and biliary secretions of the chicken.

Authors:  L Angelucci; M Baldieri; G Linari
Journal:  Eur J Pharmacol       Date:  1970-07-15       Impact factor: 4.432

5.  Cholecystokinetic activity of the new peptide caerulein in man.

Authors:  G Bertaccini; T Braibanti; F Uva
Journal:  Gastroenterology       Date:  1969-05       Impact factor: 22.682

6.  [Use of the new peptide, caeruleine, in the study of the biliary tract].

Authors:  I Orlandini; A Agosti
Journal:  Radiol Med       Date:  1969-11-01       Impact factor: 3.469

7.  [Cholecystokinin].

Authors:  S Naito; R Iwata; N Ariyama
Journal:  Horumon To Rinsho       Date:  1967-05
  7 in total
  1 in total

1.  Application of magnification radiography to the biliary system.

Authors:  S Suga; K Kimura; H Tsunekawa; M Washino; Y Hasegawa; Y Yoshida; A Fukatsu; M Iwase; S Yamazaki; A Koide; T Shimaji; M Kitamura; K Sato; S Suzuki; M Chugo; R Nagao; T Haga
Journal:  Gastroenterol Jpn       Date:  1979
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.